Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease

References

• Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):1–13. doi: 10.1016/S0140-6736(18)31694-5.
   PubMed Web of Science ®Google Scholar
• Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. doi: 10.1016/S0140-6736(20)30045-3.
   PubMed Web of Science ®Google Scholar
• Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–2045. doi: 10.2215/CJN.11491116.
   PubMed Web of Science ®Google Scholar
• Wang X, Zeng HX, Jiang L, et al. Clinical significance of glomerular autophagy in evaluation of diabetic kidney disease progression. Diabetes Metab Syndr Obes. 2022;15:1945–1959. doi: 10.2147/DMSO.S366907.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang X, Bi K, et al. Comprehensive study of tumor immune microenvironment and relevant genes in hepatocellular carcinoma identifies potential prognostic significance. Front Oncol. 2020;10:554165. doi: 10.3389/fonc.2020.554165.
   PubMed Web of Science ®Google Scholar
• Wang X, Jiang L, Liu XQ, et al. Identification of genes reveals the mechanism of cell ferroptosis in diabetic nephropathy. Front Physiol. 2022;13:890566. doi: 10.3389/fphys.2022.890566.
   PubMed Web of Science ®Google Scholar
• Wang T, Fu X, Chen Q, et al. Arachidonic acid metabolism and kidney inflammation. Int J Mol Sci. 2019;20(15):3683. doi: 10.3390/ijms20153683.
   PubMed Web of Science ®Google Scholar
• Kamata K, Hosokawa M, Matsumoto T, et al. Altered arachidonic acid-mediated responses in the perfused kidney of the streptozotocin-induced diabetic rat. J Smooth Muscle Res. 2006;42(5):171–187. doi: 10.1540/jsmr.42.171.
   PubMedGoogle Scholar
• Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J. 1989;259(2):315–324. doi: 10.1042/bj2590315.
   PubMed Web of Science ®Google Scholar
• Cole BK, Lieb DC, Dobrian AD, et al. 12- and 15-lipoxygenases in adipose tissue inflammation. Prostaglandins Other Lipid Mediat. 2013;104–105:84–92. doi: 10.1016/j.prostaglandins.2012.07.004.
   PubMed Web of Science ®Google Scholar
• Funk CD. The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta. 1996;1304(1):65–84. doi: 10.1016/s0005-2760(96)00107-5.
   PubMedGoogle Scholar
• Kang SW, Adler SG, Nast CC, et al. 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy. Kidney Int. 2001;59(4):1354–1362. doi: 10.1046/j.1523-1755.2001.0590041354.x.
   PubMed Web of Science ®Google Scholar
• Roumeliotis AK, Roumeliotis SK, Panagoutsos SA, et al. Association of ALOX12 gene polymorphism with all-cause and cardiovascular mortality in diabetic nephropathy. Int Urol Nephrol. 2018;50(2):321–329. doi: 10.1007/s11255-017-1755-z.
   PubMed Web of Science ®Google Scholar
• Liu Y, Freedman BI, Burdon KP, et al. Association of arachidonate 12-lipoxygenase genotype variation and glycemic control with albuminuria in type 2 diabetes. Am J Kidney Dis. 2008;52(2):242–250. doi: 10.1053/j.ajkd.2007.12.033.
   PubMed Web of Science ®Google Scholar
• Antonipillai I, Horton R, Natarajan R, et al. A 12-lipoxygenase product of arachidonate metabolism is involved in angiotensin action on renin release. Endocrinology. 1989;125(4):2028–2034. doi: 10.1210/endo-125-4-2028.
   PubMed Web of Science ®Google Scholar
• Franko B, Benhamou PY, Genty C, et al. RAGE and CYBA polymorphisms are associated with microalbuminuria and end-stage renal disease onset in a cohort of type 1 diabetes mellitus patients over a 20-year follow-up. Acta Diabetol. 2016;53(3):469–475. doi: 10.1007/s00592-015-0820-2.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes Care. 2018;41:S13–S27.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Liu XQ, Zhang SQ, et al. Correlation between serum carnosinase concentration and renal damage in diabetic nephropathy patients. Amino Acids. 2021;53(5):687–700. doi: 10.1007/s00726-021-02975-z.
   PubMed Web of Science ®Google Scholar
• Jongs N, Greene T, Chertow GM, et al. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol. 2021;9(11):755–766. doi: 10.1016/S2213-8587(21)00243-6.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang X, Wang M, et al. Clinical significance of interleukin 17 receptor E in diabetic nephropathy. Int Immunopharmacol. 2023;120:110324. doi: 10.1016/j.intimp.2023.110324.
   PubMed Web of Science ®Google Scholar
• Thongnak L, Pongchaidecha A, Lungkaphin A. Renal lipid metabolism and lipotoxicity in diabetes. Am J Med Sci. 2020;359(2):84–99. doi: 10.1016/j.amjms.2019.11.004.
   PubMed Web of Science ®Google Scholar
• Eid S, Abou-Kheir W, Sabra R, et al. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy. J Biol Regul Homeost Agents. 2013;27(3):693–703.
   PubMed Web of Science ®Google Scholar
• Gregus AM, Dumlao DS, Wei SC, et al. Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia. FASEB J. 2013;27(5):1939–1949. doi: 10.1096/fj.12-217414.
   PubMed Web of Science ®Google Scholar
• Kaul A, Behera MR, Rai MK, et al. Neutrophil gelatinase-associated lipocalin: as a predictor of early diabetic nephropathy in type 2 diabetes mellitus. Indian J Nephrol. 2018;28(1):53–60. doi: 10.4103/ijn.IJN_96_17.
   PubMed Web of Science ®Google Scholar
• He J, Yang B. Aquaporins in renal diseases. Int J Mol Sci. 2019;20:366.
   PubMed Web of Science ®Google Scholar
• Wang YH, Chang DY, Zhao MH, et al. Glutathione peroxidase 4 is a predictor of diabetic kidney disease progression in type 2 diabetes mellitus. Oxid Med Cell Longev. 2022;2022:2948248. doi: 10.1155/2022/2948248.
   PubMed Web of Science ®Google Scholar
• Calcagno A, Cusato J, Marinaro L, et al. Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairment. AIDS. 2016;30(6):915–920. doi: 10.1097/QAD.0000000000000995.
   PubMed Web of Science ®Google Scholar
• Levenson DJ, Simmons CEJr., Brenner BM. Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med. 1982;72(2):354–374. doi: 10.1016/0002-9343(82)90826-9.
   PubMed Web of Science ®Google Scholar
• González-Núñez D, Solé M, Natarajan R, et al. 12-Lipoxygenase metabolism in mouse distal convoluted tubule cells. Kidney Int. 2005;67(1):178–186. doi: 10.1111/j.1523-1755.2005.00068.x.
   PubMed Web of Science ®Google Scholar
• Kang SW, Natarajan R, Shahed A, et al. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes. J Am Soc Nephrol. 2003;14(12):3178–3187. doi: 10.1097/01.asn.0000099702.16315.de.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Guo QY, Wu MY, et al. p16ink4a expression is increased through 12-lipoxygenase in high glucose-stimulated glomerular mesangial cells and type 2 diabetic glomeruli. Nephron. 2015;130(2):141–150. doi: 10.1159/000431106.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Wang WN, Su SS, et al. Roles of 12-lipoxygenase and its interaction with angiotensin II on p21 and p27 expression in diabetic nephropathy. Nephron. 2019;142(1):61–70. doi: 10.1159/000496440.
   PubMed Web of Science ®Google Scholar
• Xu ZG, Miao LN, Cui YC, et al. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli. Nephrol Dial Transplant. 2009;24(6):1744–1752. doi: 10.1093/ndt/gfn703.
   PubMed Web of Science ®Google Scholar
• Porro B, Songia P, Squellerio I, et al. Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;964:26–40. doi: 10.1016/j.jchromb.2014.03.015.
   PubMed Web of Science ®Google Scholar
• Coulon L, Calzada C, Moulin P, et al. Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets. Free Radic Biol Med. 2003;35(6):616–625. doi: 10.1016/s0891-5849(03)00386-1.
   PubMed Web of Science ®Google Scholar
• Jansen MP, Emal D, Teske GJ, et al. Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. Kidney Int. 2017;91(2):352–364. doi: 10.1016/j.kint.2016.08.006.
   PubMed Web of Science ®Google Scholar
• Kühn H, O'Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 2006;45(4):334–356. doi: 10.1016/j.plipres.2006.02.003.
   PubMed Web of Science ®Google Scholar
• Rothe T, Gruber F, Uderhardt S, et al. 12/15-Lipoxygenase-mediated enzymatic lipid oxidation regulates DC maturation and function. J Clin Invest. 2015;125(5):1944–1954. doi: 10.1172/JCI78490.
   PubMed Web of Science ®Google Scholar
• Abbate M, Zoja C, Rottoli D, et al. Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney Int. 2002;61(6):2066–2077. doi: 10.1046/j.1523-1755.2002.00380.x.
   PubMed Web of Science ®Google Scholar
• Lee YH, Kim KP, Park SH, et al. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease. Nephrol Dial Transplant. 2021;36(2):295–305. doi: 10.1093/ndt/gfz168.
   PubMed Web of Science ®Google Scholar
• Huang JT, Welch JS, Ricote M, et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature. 1999;400(6742):378–382. doi: 10.1038/22572.
   PubMed Web of Science ®Google Scholar
• Okamura DM, López-Guisa JM, Koelsch K, et al. Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury. Am J Physiol Renal Physiol. 2007;293(2):F575–F585. doi: 10.1152/ajprenal.00063.2007.
   PubMed Web of Science ®Google Scholar
• Hayashida K, Kume N, Minami M, et al. Peroxisome proliferator-activated receptor a ligands increase lectin-like oxidized low density lipoprotein receptor-1 expression in vascular endothelial cells. Ann N Y Acad Sci. 2001;947(1):370–372. doi: 10.1111/j.1749-6632.2001.tb03965.x.
   PubMedGoogle Scholar
• Stadler K, Goldberg IJ, Susztak K. The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease. Curr Diab Rep. 2015;15(7):40. doi: 10.1007/s11892-015-0611-8.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang X, Li C, et al. Intracellular lipid accumulation drives the differentiation of decidual polymorphonuclear myeloid-derived suppressor cells via arachidonic acid metabolism. Front Immunol. 2022;13:868669. doi: 10.3389/fimmu.2022.868669.
   PubMed Web of Science ®Google Scholar